Doubling survival in pancreatic cancer, a long-fought rare disease approval, a massive IPO and ambitious biotech ...

This week on "The Readout LOUD": a CAR-T biotech's dramatic turnaround, and drugmakers' tactics to drive more scripts. Listen ...

The promise of a better pan-RAS inhibitor Erasca has been described as the poor man’s Revolution Medicines. Impoverished ...

Biotechnology is the application of biological organisms, cells, or molecules to produce a product or service for the betterment of humankind. This area of study includes aspects of molecular biology, ...

Biotech has long been one of the strongest sector stories of the past year, and investors who got there early have been rewarded. As of April 2, 2026, the State Street SPDR S&P Biotech ETF (NYSE:XBI) ...

John Crowley, Biotechnology Innovation Organization (BIO) president and CEO, joins 'Squawk Box' to discuss 50 years of ...

The Fight of Our Lives highlights biotech’s impact on patient lives in both the short- and long-term, urging continued ...

This was a new position; the IBB stake now accounts for 8.7% of Florin Court Capital LLP’s 13F AUM Top five holdings after the filing: ICLN: $16.6 million (13.0% of AUM) IBB: $11.1 million (8.7% of ...

The startup is developing “modified DNA” therapies it claims can combine the strengths of multiple approaches, from messenger ...

Biotech stocks are emerging from a four-year slump. The SPDR S&P Biotech exchange-traded fund XBI, a proxy for the sector, is up 25% so far this year through Oct. 31, beating the S&P 500 SPX by 9 ...

In this article, we will look at the 8 Most Undervalued Biotech Stocks to Buy Right Now.

If biotech funding continues to increase this year, Danaher could benefit.